Medical Science News

RSS

Study offers hope for treatment of Krabbe disease

In one out of 100,000 infants, a mutation in the GALC gene causes an incurable, always fatal disorder known as infantile Krabbe disease, or globoid cell leukodystrophy. Most children with the condition die before they turn 2.

26 Aug 2020

Novel cell-based therapy holds promise for obesity and diabetes

Obesity is the main cause of type 2 diabetes and related chronic illnesses that together will kill more people around the globe this year than the Covid-19 coronavirus.

26 Aug 2020

Scientists combine 3D bioprinting and computer modeling to study cancer metastasis in blood vessels

Lawrence Livermore National Laboratory scientists have paired 3D-printed, living human brain vasculature with advanced computational flow simulations to better understand tumor cell attachment to blood vessels, the first step in secondary tumor formation during cancer metastasis.

26 Aug 2020

UBC discovery may offer new treatment possibility for women with rare form of ovarian cancer

A recent finding by researchers at the BC Cancer Research Institute and the University of British Columbia may offer a new treatment possibility for people diagnosed with a rare and aggressive form of ovarian cancer.

26 Aug 2020

Researchers identify how promising therapy may work to improve adverse effects of NAFLD

A team led by researchers at Massachusetts General Hospital (MGH) has taken an important step forward in the goal of developing a potential treatment for non-alcoholic fatty liver disease (NAFLD), the most common form of chronic liver disease.

26 Aug 2020

Scientists discover possible biomarkers for detecting opioid use disorder during pregnancy

Scientists at the University of Missouri have discovered possible biological markers that they hope could one day help identify the presence of an opioid use disorder during human pregnancy.

26 Aug 2020

Studies unravel COVID-19 mysteries

A team from Lawson Health Research Institute and Western University has made significant steps forward in understanding COVID-19 through two back-to-back studies published this week in Critical Care Explorations.

26 Aug 2020

New method analyzes the whole brain network for the first time

A new method of brain imaging analysis offers the potential to greatly improve the effectiveness of noninvasive brain stimulation treatment for Alzheimer's, obsessive compulsive disorder, depression, and other conditions.

26 Aug 2020

Consuming personal fecal microbiome when dieting may limit weight regain, study shows

People who consume frozen microbiome capsules derived from their own feces when dieting may limit their weight regain, according to a new study published in Gastroenterology, conducted by a team of researchers led by researchers at Ben-Gurion University of the Negev.

26 Aug 2020

Study reveals how a cannabinoid may treat acute respiratory distress syndrome

Acute Respiratory Distress Syndrome, when caused by a bacterial toxin known as Staphylococcal enterotoxin, can be completely prevented by treatment with Δ9-tetrahydrocannabinol (THC), a cannabinoid found in the cannabis plant.

26 Aug 2020

Researchers develop novel material with possible applications in wound healing

With an increase in the elderly and aging population and also in the number of invasive surgeries, wound healing has become a critical focus area in medicine.

26 Aug 2020

Inflammatory protein produced by mast cells contributes to fibrosis in gastric cancer

Gastric cancer, one of the leading causes of cancer-associated mortality worldwide, is renowned for its ability to disseminate throughout the peritoneal cavity.

26 Aug 2020

New computational methods help find genetic causes of severe childhood brain disorders

A team of researchers at Children's Hospital of Philadelphia affiliated with the CHOP Epilepsy Neurogenetics Initiative have combined clinical information with large-scale genomic data to successfully link characteristic presentations of childhood epilepsies with specific genetic variants.

26 Aug 2020

First comparative data of encorafenib and paradox breaker inhibitors in BRAF mutant CRC

Oncotarget Volume 11, Issue 34 features Figure 1, "BRAF inhibitor-induced changes in cell viability," by Pickles, et al which reported that the BEACON CRC trial demonstrated a survival advantage over chemotherapy for a combination of targeted agents comprising the potent BRAF inhibitor encorafenib together with cetuximab and binimetinib.

26 Aug 2020

Researchers discover mechanisms underlying learning and memory formation in the brain

Seeking an answer, researchers at CHU Sainte-Justine Hospital and Université de Montréal have made a major discovery in understanding the mechanisms underlying learning and memory formation.

26 Aug 2020

$Study identifies link between hip fracture risk and nanoscale bone inflexibility$

Study identifies link between hip fracture risk and nanoscale bone inflexibility

The study led by Imperial College London found that flexibility, as well as density, in the bone nanostructure is an important factor in assessing how likely someone is to suffer fractures.

26 Aug 2020

BM32 vaccine against grass pollen allergy could be potential treatment for hepatitis B infection

Chronic hepatitis B infections represent a global health problem that could hitherto only be treated by chemotherapy.

26 Aug 2020

Blood transfusions protect the brain from stroke damage

Muscle weakness permeates through one side of your body and your speech slurs. It's a stroke. And you need to be rushed to the emergency room.

26 Aug 2020

Personalized genetic testing helps reduce adverse events following balloon angioplasty

An international, first-of-its-kind cardiology trial used personalized genetic testing to reduce by 34 per cent the number of serious adverse events following balloon angioplasty, a treatment for the most common form of heart disease.

26 Aug 2020

Preclinical studies of a COVID-19 vaccine candidate show positive results

Preclinical studies of a COVID-19 vaccine candidate at the University of Alabama at Birmingham show positive results that appear to distinguish this vaccine candidate from other vaccine candidates that are currently in advanced stages of clinical development, the Maryland-based Altimmune Inc. announced today.

25 Aug 2020

Medical Science News

Study offers hope for treatment of Krabbe disease

Novel cell-based therapy holds promise for obesity and diabetes

Scientists combine 3D bioprinting and computer modeling to study cancer metastasis in blood vessels

UBC discovery may offer new treatment possibility for women with rare form of ovarian cancer

Researchers identify how promising therapy may work to improve adverse effects of NAFLD

Scientists discover possible biomarkers for detecting opioid use disorder during pregnancy

Studies unravel COVID-19 mysteries

New method analyzes the whole brain network for the first time

Consuming personal fecal microbiome when dieting may limit weight regain, study shows

Study reveals how a cannabinoid may treat acute respiratory distress syndrome

Researchers develop novel material with possible applications in wound healing

Inflammatory protein produced by mast cells contributes to fibrosis in gastric cancer

New computational methods help find genetic causes of severe childhood brain disorders

First comparative data of encorafenib and paradox breaker inhibitors in BRAF mutant CRC

Researchers discover mechanisms underlying learning and memory formation in the brain

Study identifies link between hip fracture risk and nanoscale bone inflexibility

BM32 vaccine against grass pollen allergy could be potential treatment for hepatitis B infection

Blood transfusions protect the brain from stroke damage

Personalized genetic testing helps reduce adverse events following balloon angioplasty

Preclinical studies of a COVID-19 vaccine candidate show positive results

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News